From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.
In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.
From April 15 to 18, Ekaterinburg hosted the 6th international specialized exhibition and forum Healthcare of the Urals–2025. This year, 130 companies from 34 cities of Russia and the Republic of Belarus took part in the event, presenting over 1000 units of medical equipment and goods. The residents of the Ural Biomedical Cluster were traditionally among the participants, as well as its collective member – the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.
MedicorPharma-Ural LLC has been a supplier of equipment for nuclear medicine and radioisotope products to healthcare institutions throughout Russia and abroad for more than 10 years.
Products supplied:
- radiopharmaceuticals based on I-131, Sm-153, Sr-89;
— technetium Тс-99m generators;
— microsources of radioactive emission based on I-125;
— intraoperative gamma-probe RadPointer;
— kits for the preparation of radiopharmaceuticals labeled with 99mTc;
— other products for nuclear medicine.
MedicorPharma-Ural LLC provides services for:
— support in customs clearance of radioisotope medical products for export and import operations;
— transportation of radioactive cargo (hazard class 7);
— development of projects for bringing goods and services to the Russian market;
— registration of the shipping packaging set;
— training in the use of medical devices and radiopharmaceuticals; – and others.
The company is a manufacturer of the RadPointer gamma- probe and 99mTc-labeled radiopharmaceutical preparation kits for high-tech patient care.
The RadPointer Intraoperative Gamma-Probe is designed to search for and localize sentinel lymph nodes during diagnostic and surgical procedures.
Sentiscan®, 99mTc is a kit for the preparation of a radiopharmaceutical labeled with 99mTc, which is a nanocolloidal aluminum solution.
It is used for scintigraphic imaging and intraoperative detection of sentinel lymph nodes in patients with various malignant neoplasms (including breast, melanoma of the skin, larynx and laryngopharynx, oral mucosa, vulva, cervix, endometrium, etc.).
Also, the line of kits for the preparation of diagnostic radiopharmaceuticals produced by MedicorPharma-Ural LLC includes drugs for the diagnosis of malignant tumors of the prostate, brain and neuroendocrine tumors.
MedicorPharma-Ural LLC has all the necessary licenses, including a license to operate radiation sources and to carry out pharmaceutical activities. It is also certified according to international operating standards ISO 9001:2015 (GOST R ISO 9001-2015 Quality management systems. Requirements), ISO 13485:2017 (GOST ISO 13485-2017 Medical devices. Quality management systems. Requirements for regulatory purposes).
28/1, Kirova St., Ekaterinburg
+7 (343) 270-75-29
8 800 600 33 90